The Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables are here!

On February 15, Tianjin Pharmaceutical Purchasing Center released the "Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Procurement and Use Work Plan with Volume Linkage
.
The product of this centralized and volume-linked procurement is coronary dilation balloon with a fast-exchange structure.
The first 15 digits of the medical consumables code of the National Medical Insurance Bureau are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant
.
Purchasing units are distinguished according to registration certificates and functional attributes, and the same purchasing unit includes all specifications and models
.
The main procurement entities are all public medical institutions (including military medical institutions) in Beijing, Tianjin, Hebei, Xinjiang and the Corps
.
At the same time, medical insurance designated social medical institutions are encouraged to actively participate
.
Support the participation of medical institutions in other provinces (autonomous regions and municipalities) in the "3+N" Pharmaceutical Coalition Procurement Alliance
.
The original text is as follows: According to the "Opinions of the Central Committee of the Communist Party of China and the State Council on Deepening the Reform of the Medical Security System" and the "Notice of the General Office of the State Council on Printing and Distributing the Reform Plan for Governing High-value Medical Consumables" (Guobanfa [2019] No.
37), "On the Development of State Organizations" Guiding Opinions on the Centralized Procurement and Use of High-value Medical Consumables (No.
31 [2021] of the Medical Insurance), "Opinions on the Joint Procurement of Medicines in the Beijing-Tianjin-Hebei Region" (No.
34 of Beijing Medical Insurance [2020]) and other documents, In accordance with the "Notice on the Development of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon-type Medical Consumables Linkage Procurement Project", in order to do a good job in the Beijing-Tianjin-Hebei "3+N" Alliance coronary artery expansion balloon The second procurement agreement period for similar medical consumables will be linked to the procurement and use of volume.
This work plan is formulated after the research and decision of the Beijing-Tianjin-Hebei Xinhe Corps medical security department and based on the actual situation
.
1.
Working Organizations Beijing Pharmaceutical Centralized Purchasing Service Center, Tianjin Pharmaceutical Purchasing Center, and Hebei Province Medical Drugs and Devices Centralized Purchasing Center, together as the working organization for the linked procurement of coronary artery dilation balloon medical consumables, relying on the Beijing-Tianjin-Hebei Pharmaceutical Co.
, Ltd.
The procurement platform is responsible for the specific implementation of procurement work
.
The medical security department in the Beijing-Tianjin-Hebei "3+N" alliance area is responsible for formulating and implementing the implementation of the territorial selection results and supporting policies, etc.

.
2.
Procurement varieties This time, the centralized and volume-linked procurement varieties are coronary dilatation balloons with a fast-exchange structure.
The first 15 digits of the medical consumables code of the National Medical Insurance Bureau are C02020500200001 or C02020500200003, and their functional attributes include semi-compliant and non-compliant.

.
Purchasing units are distinguished according to registration certificates and functional attributes, and the same purchasing unit includes all specifications and models
.
3.
Procurement subjects Beijing, Tianjin, Hebei, Xinjiang and all public medical institutions of the XPCC (including military medical institutions) form a procurement alliance to implement joint procurement with volume
.
Encourage medical insurance designated social medical institutions to actively participate
.
Support the participation of medical institutions in other provinces (autonomous regions and municipalities) in the "3+N" Pharmaceutical Coalition Procurement Alliance
.
4.
Procurement cycle This time the procurement cycle of coronary artery dilation balloon medical consumables is aligned and synchronized with the centralized procurement cycle of coronary stents organized by the state.
The actual execution date of the selected results will be determined by the alliance region to ensure that after the expiration of the first-year agreement The second-year agreement period will be smoothly and orderly connected
.
V.
Procurement methods and procurement requirements (1) After fair competition review, the centralized procurement method of coronary artery dilation balloon medical consumables with volume is a combination of volume and two-way selection, that is, according to the use needs of the purchaser, with reference to the overall market price level , comprehensive quality and other factors, on the basis of the results of the selection in the first agreement period, link the purchase prices of the provinces (autonomous regions and municipalities) across the country with quantity, through mutual selection between buyers and sellers, determine the selected products, and subcontract according to the quantity.

.
(2) During the purchase cycle, the purchaser will give priority to the selected products using the volume of coronary dilation balloon medical consumables linked to purchase the selected products, and ensure the completion of the agreed purchase volume
.
On this basis, the purchaser can purchase other coronary artery dilation balloon medical consumable products in appropriate amounts in accordance with the relevant regulations on the centralized procurement management of medical consumables in the province where they are located
.
(3) During the procurement cycle, the procurement entity completes the agreed procurement volume.
For the part exceeding the agreed procurement volume, the selected enterprise still needs to supply at the selected price until the procurement cycle expires.

.
(4) During the procurement cycle, if the price selected for the procurement with quantity in other regions is lower than the price selected for the linked procurement with volume this time, the price linkage shall be implemented
.
6.
Enterprise application requirements Medical device registrants (agents) who have obtained the legal qualifications for the products within the scope of this volume-linked procurement and meet the following requirements can participate as application enterprises
.
Among them, overseas medical device registrants (agents) should designate domestic enterprise legal persons to assist them in fulfilling their corresponding legal obligations
.
(1) The products of the declared enterprise shall meet the quality standard requirements of the relevant state departments, and the production shall be organized according to the requirements of the relevant state departments
.
(2) The applicant enterprise must promise that all specifications and models of the selected products will meet the procurement needs of the alliance area within the procurement cycle, maintain the continuity of the accompanying service supply before and after the linked procurement, maintain the service content unchanged, and agree that the relevant credit commitments can be carried out according to work needs.
public
.
(3) The declared enterprise shall abide by the relevant laws and regulations such as the Patent Law of the People's Republic of China and the Anti-Unfair Competition Law of the People's Republic of China
.
(4) The declared enterprise has not been included in the current "National Pharmaceutical Price and Risk Warning List of Untrustworthy Enterprises in Recruitment and Procurement"
.
(5) Products with the same medical device registration certificate shall not be entrusted to different enterprises for declaration
.
(6) The applicant enterprise must participate within the specified time and complete the relevant system operations
.
(7) This volume-linked procurement work relies on the Beijing-Tianjin-Hebei pharmaceutical joint procurement platform, and the applicant enterprises must obtain the Beijing-Tianjin-Hebei pharmaceutical joint procurement digital certificate in accordance with the requirements listed in the notice
.
Enterprises that have already obtained digital certificates do not need to obtain them again
.
7.
Workflow (1) Collect price data of declared enterprises
.
The applicant company should log in to the Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform to view the product information of the company's coronary artery dilation balloon medical consumables, and fill in the product price according to the purchase unit.
The smallest retail package (units) is the unit of measurement
.
For the declared product selected in the first purchase agreement period (hereinafter referred to as the selected product), the corresponding selected price and the proposed supply price in each volume procurement project across the country should be truthfully filled in.
In principle, the proposed supply price should not be higher than the product in The lowest price selected for purchasing with quantity in all regions of the country
.
For the declared products that are not selected in the first purchase agreement period (hereinafter referred to as “unselected products”), if they are selected in various procurement projects with volume nationwide, the corresponding selected price and The proposed supply price, in principle, the proposed supply price shall not be higher than the lowest price of the product selected in the procurement with volume in various regions of the country, nor shall it be higher than the highest price of the lowest price selected by the same purchasing unit for the selected product in the procurement with volume in various regions.
; If you are not selected in any quantity-based procurement projects nationwide, directly fill in the proposed supply price, which, in principle, shall not be higher than the highest price among the lowest prices selected by the same procurement unit for the selected products in each region’s volume-based procurement (unit: " Yuan", rounded to 2 decimal places)
.
The announcement time of the declared product procurement unit: 10:00 on February 21, 2022 to 17:00 on February 23, 2022
.
Quotation time for selected products: from 10:00 on February 24, 2022 to 12:00 on February 28, 2022
.
Announcement time of the lowest selected price of the selected products: from 14:00 on February 28, 2022 to 17:00 on March 2, 2022
.
Quotation time for products that have not been selected: from 12:00 on March 3 to 12:00 on March 7, 2022
.
Proposed supply price announcement time: from 14:00 on March 8, 2022 to 17:00 on March 10, 2022
.
(2) Collect historical procurement data and intended procurement volume of procurement entities
.
All regions of the alliance organize procurement entities within their jurisdiction, log on to the Beijing-Tianjin-Hebei Pharmaceutical Joint Procurement Platform, refer to the historical procurement volume and proposed supply price of all coronary dilation balloon medical consumables in 2021, and organize coronary stents with the national organization.
Keep a reasonable proportion of the purchase demand with volume, and fill in the purchase demand of coronary artery dilation balloon medical consumables as of December 31, 2022 in combination with the deadline of the previous purchase agreement period in each region of the alliance, and specific to the purchase unit
.
In order to ensure the seriousness and accuracy of data reporting, each purchasing entity must upload a letter of authorization signed and confirmed by the purchasing entity when filling in relevant data on the platform
.
In principle, the purchase demand filled in by the purchaser is taken as the intended purchase amount for this volume-linked purchase
.
Time schedule: From 10:00 on March 11, 2022 to 17:00 on March 21, 2022
.
(3) Two-way selection between the declaration enterprise and the purchasing entity to form the selected products and the amount of tasks
.
The applicant enterprise confirms the supply intention according to the purchase volume of the purchaser and in combination with its own supply capacity
.
For the declaration company to confirm the supply, select Success
.
The successful selection of both parties is the selected product
.
If the declared enterprise refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the procurement entity shall redistribute it to other declared products that meet the conditions and the same functional attributes, such as the declared products allocated to the previous rounds of confirmed supply, in principle, the enterprise cannot refuse to supply , that is, the selection is successful; if it is allocated to the declared product that has not been allocated the intended purchase volume in the previous rounds, the declared enterprise will continue to confirm the supply intention
.
Purchasing entities may allocate the intended purchase volume in multiple rounds
.
Time schedule: From 10:00 on March 22 to 17:00 on March 25, 2022, the first round of confirmation must be completed before 17:00 on March 23
.
(4) Sign an agreement and implement online purchases
.
According to the requirements of the territorial medical security department, the purchaser, the successfully selected declaration enterprise, and the distribution enterprise determined by the declaration enterprise shall sign a purchase and sale agreement at the selected price
.
The agreement should specify the variety, functional attributes, quantity, price, delivery time limit, payment procedure and time, performance method, and liability for breach of contract
.
Purchasing entities should strictly implement the online procurement of medical consumables in accordance with the requirements of the local medical security department
.
The territorial medical security department should strengthen supervision, and punish medical institutions that do not purchase and use the selected products in accordance with the regulations in the performance evaluation of public hospitals, the formulation of the total medical insurance index, the management evaluation of fixed-point agreements, and the target responsibility evaluation of the person in charge of the medical institution.

.
The actual implementation date of the selected results shall be determined by the local medical security department
.
8.
Contact information Beijing Pharmaceutical Centralized Purchasing Service Center Tel: 010-89152634 Fax: 010-89152614 Service hours: 9:00-11:30, 14:00-17:00, excluding holidays
.
Tianjin Pharmaceutical Purchasing Center Tel: 022-24538156, 022-24538157 Fax: 022-24538991 Service hours: 9:00-11:30, 14:00-17:00, except holidays
.
Hebei Province Centralized Purchasing Center for Medical Drugs and Devices Tel: 0311-66906539 Fax: 0311-66906539 Service hours: 9:00-11:30, 14:00-17:00, except holidays
.
Beijing Pharmaceutical Centralized Purchasing Service Center Tianjin Pharmaceutical Purchasing Center Hebei Province Medical Drug Equipment Centralized Purchasing Center February 15, 2022